Candel Therapeutics Inc
NASDAQ:CADL
Cash Flow Statement
Cash Flow Statement
Candel Therapeutics Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(18)
|
(20)
|
(35)
|
(48)
|
(36)
|
(33)
|
(20)
|
(12)
|
(19)
|
(27)
|
(32)
|
(32)
|
(38)
|
(37)
|
(50)
|
(52)
|
(55)
|
(40)
|
(22)
|
(23)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
2
|
3
|
3
|
5
|
3
|
3
|
2
|
1
|
2
|
3
|
3
|
3
|
3
|
3
|
5
|
5
|
5
|
5
|
4
|
4
|
|
| Other Non-Cash Items |
7
|
8
|
20
|
30
|
15
|
6
|
(11)
|
(21)
|
(13)
|
(6)
|
(0)
|
(1)
|
3
|
4
|
19
|
21
|
27
|
11
|
(9)
|
(11)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
|
| Change in Working Capital |
2
|
0
|
(0)
|
(2)
|
(1)
|
1
|
3
|
2
|
0
|
(3)
|
(3)
|
(2)
|
(1)
|
0
|
(1)
|
1
|
0
|
0
|
(0)
|
(1)
|
|
| Cash from Operating Activities |
(9)
N/A
|
(12)
-38%
|
(15)
-20%
|
(20)
-36%
|
(22)
-9%
|
(25)
-11%
|
(27)
-11%
|
(30)
-9%
|
(31)
-6%
|
(34)
-9%
|
(34)
0%
|
(34)
+2%
|
(34)
-2%
|
(32)
+7%
|
(31)
+3%
|
(29)
+7%
|
(27)
+6%
|
(27)
-1%
|
(30)
-10%
|
(34)
-12%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
40
|
21
|
21
|
21
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
38
N/A
|
19
-51%
|
19
-2%
|
19
+2%
|
(2)
N/A
|
(2)
+3%
|
(2)
+4%
|
(2)
+10%
|
(1)
+15%
|
(1)
+15%
|
(1)
+42%
|
(1)
+17%
|
(0)
+47%
|
(0)
-9%
|
(0)
+53%
|
(0)
+72%
|
(0)
+60%
|
(0)
+25%
|
(0)
-208%
|
(0)
-316%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
72
|
72
|
72
|
71
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
5
|
9
|
103
|
104
|
119
|
114
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
20
|
20
|
20
|
20
|
0
|
0
|
0
|
0
|
(2)
|
(4)
|
(7)
|
(9)
|
(10)
|
(10)
|
(10)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash from Financing Activities |
0
N/A
|
1
+23%
|
0
-21%
|
72
+15 054%
|
72
0%
|
92
+28%
|
91
0%
|
20
-78%
|
20
+0%
|
0
-100%
|
0
-38%
|
0
N/A
|
(0)
N/A
|
(1)
-1 037%
|
1
N/A
|
2
+295%
|
94
+4 098%
|
94
-1%
|
109
+17%
|
104
-5%
|
|
| Change in Cash | |||||||||||||||||||||
| Net Change in Cash |
30
N/A
|
7
-76%
|
4
-44%
|
70
+1 667%
|
48
-32%
|
65
+37%
|
62
-4%
|
(11)
N/A
|
(13)
-12%
|
(35)
-177%
|
(35)
+1%
|
(34)
+2%
|
(35)
-1%
|
(34)
+3%
|
(30)
+9%
|
(26)
+13%
|
67
N/A
|
66
-1%
|
79
+19%
|
70
-11%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(11)
N/A
|
(14)
-35%
|
(17)
-21%
|
(22)
-30%
|
(24)
-8%
|
(26)
-10%
|
(29)
-10%
|
(31)
-8%
|
(33)
-5%
|
(35)
-8%
|
(35)
+1%
|
(34)
+2%
|
(35)
-1%
|
(32)
+7%
|
(31)
+4%
|
(29)
+8%
|
(27)
+6%
|
(27)
-1%
|
(30)
-10%
|
(34)
-13%
|
|